Meeting
2013 ASCO Annual Meeting
The impact of diabetes mellitus and metformin on survival of patients with advanced pancreatic cancer receiving chemotherapy.
Authors
Do-Youn Oh
Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
Do-Youn Oh , Younak Choi , Tae-Yong Kim , Kyung-Hun Lee , Sae-Won Han , Seock-Ah Im , Tae-You Kim , Yung-Jue Bang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 4044)
DOI
10.1200/jco.2013.31.15_suppl.4044
Abstract #
4044
Poster Bd #
16F
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Advanced pancreatic cancer outcomes and the impact of COVID-19 pandemic: The experience of an academic cancer center.
First Author: Christian Adams-Carey
Poster
2022 ASCO Annual Meeting
Phase 2 Quilt 88 trial of DAMP inducers combined with IL15 superagonist, N-803, and anti–PD-L1 NK cell therapy more than doubles historical overall survival in patients with third- to sixth-line advanced pancreatic cancer.
First Author: Tara Elisabeth Seery
Poster
2018 ASCO Annual Meeting
Prognostic benefit of taking statin and/or metformin in elderly patients with advanced non-small cell lung cancer: A nationwide population-based epidemiologic study.
First Author: Yun-Gyoo Lee
Poster
2017 Gastrointestinal Cancers Symposium
Evaluating associations of diabetes, insulin use, and BMI with efficacy in patients with resected pancreatic cancer: An ancillary analysis of NRG Oncology/RTOG 9704.
First Author: Theodore S. Hong